Meitheal Pharmaceuticals specializes in research, manufacturing, and supply of injection medicine.
Meitheal Pharmaceuticals has raised $35.0M in total funding. The most recent round was Debt Financing. The last funding was announced in August 2023.
Meitheal Pharmaceuticals's investors include JP Morgan.
Meitheal Pharmaceuticals is headquartered in Chicago, United States.
Meitheal Pharmaceuticals specializes in research, manufacturing, and supply of injection medicine.
Meitheal Pharmaceuticals is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Meitheal Pharmaceuticals — Funding & Investors." VCBacked, August 22, 2023, https://www.vcbacked.co/company/meitheal-pharmaceuticals. Accessed September 15, 2026.
VCBacked. (2023). Meitheal Pharmaceuticals — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/meitheal-pharmaceuticals
{{cite web |title=Meitheal Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/meitheal-pharmaceuticals |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated